𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer risk and mortality in users of calcium channel blockers : A cohort study

✍ Scribed by Henrik T. Sørensen; Jørgen H. Olsen; Lene Mellemkjær; Ane Marie Thulstrup; Flemming H. Steffensen; Joseph K. McLaughlin; John A. Baron

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
75 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcium channel blockers, cancer inciden
Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. Women : The Nurses' Health Study
✍ Karin B. Michels; Bernard A. Rosner; Alexander M. Walker; Meir J. Stampfer; JoAn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

BACKGROUND. Some studies have suggested that the use of calcium channel blockers may increase the risk of cancer. A possible association of the use of calcium channel blockers with cancer incidence and cancer mortality was addressed using data from the Nurses' Health Study. ## METHODS. In this st

Use of calcium channel blockers and brea
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
✍ Annette L. Fitzpatrick; Janet R. Daling; Curt D. Furberg; Richard A. Kronmal; Jo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

and Modification codes. Time-dependent Cox proportional hazards regression models Department of Epidemiology, University of were used to assess associations between incident breast carcinoma and the use of Washington, Seattle, Washington. specific antihypertensive medication including calcium chann

Use of calcium channel blockers and beta
Use of calcium channel blockers and beta blockers as antihypertensives in relation to mortality in type 2 diabetes patients: a population-based observational study
✍ Gunnar Lindberg; Jonny Olsson; Arne Melander 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Objectives: In previous trials, patients with type 2 diabetes using calcium channel blockers (ccb) have suffered a less favourable outcome when compared with patients on other treatments. the present study was designed to compare mortality in type 2 diabetes patients using either ccb or beta blo